These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 24212976)

  • 1. The translocator protein radioligand 18F-DPA-714 monitors antitumor effect of erufosine in a rat 9L intracranial glioma model.
    Awde AR; Boisgard R; Thézé B; Dubois A; Zheng J; Dollé F; Jacobs AH; Tavitian B; Winkeler A
    J Nucl Med; 2013 Dec; 54(12):2125-31. PubMed ID: 24212976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative preclinical imaging of TSPO expression in glioma using N,N-diethyl-2-(2-(4-(2-18F-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide.
    Tang D; Hight MR; McKinley ET; Fu A; Buck JR; Smith RA; Tantawy MN; Peterson TE; Colvin DC; Ansari MS; Nickels M; Manning HC
    J Nucl Med; 2012 Feb; 53(2):287-94. PubMed ID: 22251555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The translocator protein ligand [¹⁸F]DPA-714 images glioma and activated microglia in vivo.
    Winkeler A; Boisgard R; Awde AR; Dubois A; Thézé B; Zheng J; Ciobanu L; Dollé F; Viel T; Jacobs AH; Tavitian B
    Eur J Nucl Med Mol Imaging; 2012 May; 39(5):811-23. PubMed ID: 22270507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of the translocator protein radioligands 11C-DPA-713, 18F-DPA-714, and 11C-PK11195 in a rat model of acute neuroinflammation.
    Chauveau F; Van Camp N; Dollé F; Kuhnast B; Hinnen F; Damont A; Boutin H; James M; Kassiou M; Tavitian B
    J Nucl Med; 2009 Mar; 50(3):468-76. PubMed ID: 19223401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging microglial/macrophage activation in spinal cords of experimental autoimmune encephalomyelitis rats by positron emission tomography using the mitochondrial 18 kDa translocator protein radioligand [¹⁸F]DPA-714.
    Abourbeh G; Thézé B; Maroy R; Dubois A; Brulon V; Fontyn Y; Dollé F; Tavitian B; Boisgard R
    J Neurosci; 2012 Apr; 32(17):5728-36. PubMed ID: 22539835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the PBR/TSPO radioligand [(18)F]DPA-714 in a rat model of focal cerebral ischemia.
    Martín A; Boisgard R; Thézé B; Van Camp N; Kuhnast B; Damont A; Kassiou M; Dollé F; Tavitian B
    J Cereb Blood Flow Metab; 2010 Jan; 30(1):230-41. PubMed ID: 19794397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TSPO-PET and diffusion-weighted MRI for imaging a mouse model of infiltrative human glioma.
    Pigeon H; Pérès EA; Truillet C; Jego B; Boumezbeur F; Caillé F; Zinnhardt B; Jacobs AH; Le Bihan D; Winkeler A
    Neuro Oncol; 2019 Jun; 21(6):755-764. PubMed ID: 30721979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preclinical Evaluation of a Novel TSPO PET Ligand 2-(7-Butyl-2-(4-(2-[
    Tang D; Li J; Nickels ML; Huang G; Cohen AS; Manning HC
    Mol Imaging Biol; 2019 Feb; 21(1):113-121. PubMed ID: 29869061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical imaging evaluation of novel TSPO-PET ligand 2-(5,7-Diethyl-2-(4-(2-[(18)F]fluoroethoxy)phenyl)pyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide ([ (18)F]VUIIS1008) in glioma.
    Tang D; Nickels ML; Tantawy MN; Buck JR; Manning HC
    Mol Imaging Biol; 2014 Dec; 16(6):813-20. PubMed ID: 24845529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Akt-inhibitor Erufosine induces apoptotic cell death in prostate cancer cells and increases the short term effects of ionizing radiation.
    Rudner J; Ruiner CE; Handrick R; Eibl HJ; Belka C; Jendrossek V
    Radiat Oncol; 2010 Nov; 5():108. PubMed ID: 21080918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of PET Imaging Performance of the TSPO Radioligand [18F]DPA-714 in Mouse and Rat Models of Cancer and Inflammation.
    Zheng J; Winkeler A; Peyronneau MA; Dollé F; Boisgard R
    Mol Imaging Biol; 2016 Feb; 18(1):127-34. PubMed ID: 26194010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of TSPO overexpression in a rat model of local neuroinflammation induced by intracerebral injection of LPS by the use of [(18)F]DPA-714 PET.
    Ory D; Postnov A; Koole M; Celen S; de Laat B; Verbruggen A; Van Laere K; Bormans G; Casteels C
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):163-172. PubMed ID: 26323575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET imaging of neuroinflammation in a rat traumatic brain injury model with radiolabeled TSPO ligand DPA-714.
    Wang Y; Yue X; Kiesewetter DO; Niu G; Teng G; Chen X
    Eur J Nucl Med Mol Imaging; 2014 Jul; 41(7):1440-9. PubMed ID: 24615467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential involvement of F0F1-ATP(synth)ase and reactive oxygen species in apoptosis induction by the antineoplastic agent erucylphosphohomocholine in glioblastoma cell lines : a mechanism for induction of apoptosis via the 18 kDa mitochondrial translocator protein.
    Veenman L; Alten J; Linnemannstöns K; Shandalov Y; Zeno S; Lakomek M; Gavish M; Kugler W
    Apoptosis; 2010 Jul; 15(7):753-68. PubMed ID: 20107899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DPA-714, a new translocator protein-specific ligand: synthesis, radiofluorination, and pharmacologic characterization.
    James ML; Fulton RR; Vercoullie J; Henderson DJ; Garreau L; Chalon S; Dolle F; Costa B; Guilloteau D; Kassiou M
    J Nucl Med; 2008 May; 49(5):814-22. PubMed ID: 18413395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo imaging and characterization of [(18)F]DPA-714, a potential new TSPO ligand, in mouse brain and peripheral tissues using small-animal PET.
    Vicidomini C; Panico M; Greco A; Gargiulo S; Coda AR; Zannetti A; Gramanzini M; Roviello GN; Quarantelli M; Alfano B; Tavitian B; Dollé F; Salvatore M; Brunetti A; Pappatà S
    Nucl Med Biol; 2015 Mar; 42(3):309-16. PubMed ID: 25537727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ether analogues of DPA-714 with subnanomolar affinity for the translocator protein (TSPO).
    Banister SD; Beinat C; Wilkinson SM; Shen B; Bartoli C; Selleri S; Da Pozzo E; Martini C; Chin FT; Kassiou M
    Eur J Med Chem; 2015 Mar; 93():392-400. PubMed ID: 25725375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel Pyrazolo[1,5-a]pyrimidines as Translocator Protein 18 kDa (TSPO) Ligands: Synthesis, in Vitro Biological Evaluation, [(18)F]-Labeling, and in Vivo Neuroinflammation PET Images.
    Damont A; Médran-Navarrete V; Cacheux F; Kuhnast B; Pottier G; Bernards N; Marguet F; Puech F; Boisgard R; Dollé F
    J Med Chem; 2015 Sep; 58(18):7449-64. PubMed ID: 26280386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism and quantification of [(18)F]DPA-714, a new TSPO positron emission tomography radioligand.
    Peyronneau MA; Saba W; Goutal S; Damont A; Dollé F; Kassiou M; Bottlaender M; Valette H
    Drug Metab Dispos; 2013 Jan; 41(1):122-31. PubMed ID: 23065531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [11C]-DPA-713 and [18F]-DPA-714 as new PET tracers for TSPO: a comparison with [11C]-(R)-PK11195 in a rat model of herpes encephalitis.
    Doorduin J; Klein HC; Dierckx RA; James M; Kassiou M; de Vries EF
    Mol Imaging Biol; 2009; 11(6):386-98. PubMed ID: 19330384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.